Abliva AB (publ)
NEVPF · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $502 | $128 | $133 | $114 |
| - Cash | $33 | $47 | $45 | $31 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $469 | $81 | $88 | $83 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$26 | -$19 | -$25 | -$18 |
| % Margin | – | – | – | – |
| Net Income | -$26 | -$20 | -$26 | -$18 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.021 | -0.016 | -0.02 | -0.017 |
| % Growth | -35.5% | 24% | -18.6% | – |
| Operating Cash Flow | -$14 | -$37 | -$26 | -$26 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$14 | -$38 | -$26 | -$26 |